SRF Q1 FY27 Results: Profit Surges 76% on 31.8% Revenue Jump as Specialty Chemicals Recovery Accelerates

The Quick Take

• SRF Limited reported Q1 FY27 net profit growth of 76% year-on-year as revenue from operations rose 31.8% to Rs 5,033 crore from Rs 3,819 crore a year ago.
• The company also announced a dividend, reflecting management confidence in cash generation and a commitment to returning value to shareholders alongside strong earnings growth.
• SRF's results signal a broad-based recovery in India's specialty chemicals sector after a period of inventory destocking and pricing pressure from Chinese competition.

SRF Limited's 76% profit surge on 31.8% revenue growth represents one of the strongest Q1 FY27 performances in India's specialty chemicals space. The company's diversified business — spanning fluorochemicals, technical textiles, packaging films, and refrigerant gases — means its revenue recovery reflects broad-based industrial demand improvement rather than strength in a single product segment. Revenue of Rs 5,033 crore versus Rs 3,819 crore a year ago indicates that both volume and pricing have improved substantially from the destocked and pressure environment that characterised the previous several quarters.

India's specialty chemicals sector has been in a recovery trajectory after a difficult 18-24 month period when Chinese manufacturers flooded global markets with aggressively priced inventory, compressing margins for Indian producers. SRF's fluorochemicals business — particularly its portfolio of HFCs and HFOs — has benefited from both improving global pricing and India's growing domestic demand for refrigerants as air conditioning penetration rises. The company's capital investments in new capacity, including its flagship Bhiwadi complex, position it to capture incremental market share as global customers seek to diversify supply chains away from China.

The dividend announcement alongside strong earnings reinforces the investment thesis that SRF has successfully navigated through the sector's trough and is now generating sufficient free cash flow to both invest in growth and return capital to shareholders. For institutional investors in Indian specialty chemicals — a sector that commands premium valuations on the expectation of sustained above-GDP growth — SRF's Q1 print validates the thesis and sets a high benchmark for peer results from Navin Fluorine, Aarti Industries, and Deepak Nitrite to confirm whether the sector recovery is uniform or concentrated in select leaders.

Synthesized from 1 source.